title: Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
abstract: It is currently unclear whether intestinal metaplasia at the esophagogastric junction and in the distal esophagus represent a continuum of the same underlying disease process, i.e., gastroesophageal reflux, or constitute different entities with a different pathogenesis. Biopsies below the Z line might show specialized epithelium in some patients and the question is whether this is another form of short segment Barrett's esophagus or whether it is related to a generalized atrophic process of the stomach. Data from recent studies regarding the expression of cytokeratin CK7 and CK20 in intestinal metaplasia (IM) found at the gastroesophageal junction are conflicting. Prompted by these data we undertook the present study: a) to evaluate the expression of CK7 and CK20 in IM of the gastric cardia and to compare the findings with those in patients with Barrett's esophagus and IM of the gastric corpus and antrum mucosa; and b) to evaluate the immunophenotype of non-intestinalized cardiac mucosa and to compare it with that of normal gastric epithelium. We studied the expression of CK7 and CK20 on biopsy specimens from patients with long-segment Barrett's esophagus (n=17) and surgical resection and biopsy specimens of gastric cardia (n=15), corpus (n=14) and antrum (n=22) from patients with histological evidence of IM. Eighty-four biopsy specimens from 42 patients (antrum n=15, corpus n=20, cardia n=7) without evidence of IM were studied as a control group. We observed an immunophenotype characterised by diffuse moderate to strong CK7 staining on the surface and crypt epithelium combined with strong CK20 staining on the surface and superficial part of the crypts in 94.1% (16/17) of the cases with long-segment Barrett's esophagus, but in none of the 36 cases with IM in distal stomach (antrum and corpus). IM in the gastric cardia expressed the immunophenotype seen in IM of the gastric mucosa in 93.3% (14/15) of the cases. On the other hand, normal cardiac epithelium expressed patchy strong CK7 staining on the surface epithelium and on both, superficial and deep parts of the pits combined with patchy strong CK20 staining on the surface epithelium and superficial pits, a feature permitting distinction of the normal cardiac epithelium from those of the normal gastric antrum and corpus epithelium. We conclude that the expression of cytokeratins 7 and 20 can be used to distinguish the origin of IM of the gastroesophageal junction. The CK7/20 immunophenotype of IM in the gastric cardia closely resembles that of the IM in the gastric antrum and corpus and is different from IM in long-segment Barrett's esophagus. In contrast, the CK7/20 immunophenotype of the cardiac epithelium is different from that of the gastric antrum and corpus mucosa, suggesting that cardiac epithelium might not be a native normal gastric epithelium but one that is acquired as a consequence of longstanding inflammation. Changing pattern of CK7 and CK20 expression from normal to intestinalized epithelium suggests that IM arising from cardiac epithelium might have distinctive features.
authors.affiliation: Institute of Digestive Disease-University Clinical Center of Serbia, Belgrade, Yugoslavia.
authors.forename: I
authors.initials: I
authors.lastname: Jovanovic
authors.forename: M
authors.initials: M
authors.lastname: Tzardi
authors.forename: I A
authors.initials: IA
authors.lastname: Mouzas
authors.forename: M
authors.initials: M
authors.lastname: Micev
authors.forename: P
authors.initials: P
authors.lastname: Pesko
authors.forename: T
authors.initials: T
authors.lastname: Milosavljevic
authors.forename: M
authors.initials: M
authors.lastname: Zois
authors.forename: M
authors.initials: M
authors.lastname: Sganzos
authors.forename: G
authors.initials: G
authors.lastname: Delides
authors.forename: P
authors.initials: P
authors.lastname: Kanavaros
mesh_terms: D001471:Barrett Esophagus / Q000378:metabolism* / Q000473:pathology; D002299:Cardia / Q000378:metabolism / Q000473:pathology; D005753:Gastric Mucosa / Q000378:metabolism* / Q000473:pathology; D007381:Intermediate Filament Proteins / Q000096:biosynthesis*; D053554:Keratin-20; D053552:Keratin-7; D007633:Keratins / Q000096:biosynthesis*; D011706:Pyloric Antrum / Q000378:metabolism / Q000473:pathology; D013272:Stomach Diseases / Q000378:metabolism* / Q000473:pathology
chemical_list: D007381:Intermediate Filament Proteins; D053554:Keratin-20; D053552:Keratin-7; D007633:Keratins